By: Emily Brooks, Joseph Choi, Nathaniel Weixel
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years after being declared in shortage by the Food and Drug Administration (FDA).
Emily Brooks is a politics reporter at the Washington Examiner, with a focus on covering the 2020 campaign. Her work has appeared in various news outlets, including The Hill, CW33, The Fresno Bee, and Yahoo News. She has also been featured on television and radio stations such as WIVB/WNLO-TV, WDAF-TV FOX4, and WGN Radio AM 720.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Emily's coverage is heavily focused on government and politics, particularly within the United States. She appears to be interested in legal policy regulation and government announcements related to political figures and events.
Given her focus on national politics, Emily may be most responsive to pitches involving expert commentary or analysis on recent legislative developments, political endorsements, border policies, or activities of prominent political figures such as House representatives and members of the Biden administration.
It would also be beneficial to offer insights from experts with a deep understanding of US legal policy regulations and their impact on governmental decisions.
This information evolves through artificial intelligence and human feedback. Improve this profile .